These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

249 related items for PubMed ID: 6140282

  • 21. [H2 receptor antagonists in the therapy of peptic ulcer disease].
    Dammann HG, Dau B, Dreyer M, Müller P, Simon B.
    Z Gastroenterol; 1987 Aug; 25 Suppl 3():136-45. PubMed ID: 2889298
    [Abstract] [Full Text] [Related]

  • 22. [Peptic ulcer: new aspects of conservative therapy].
    Bernoulli R.
    Schweiz Med Wochenschr; 1977 May 07; 107(18):618-22. PubMed ID: 17157
    [Abstract] [Full Text] [Related]

  • 23. The other option in peptic ulcer therapy.
    Halter F.
    S Afr Med J; 1984 Jun 23; 65(25):996-1000. PubMed ID: 6374932
    [Abstract] [Full Text] [Related]

  • 24. [Medical therapy of peptic ulcer: problems and prospects].
    Trabucchi E, Foschi D, Belloli P, Montorsi F, Marchetti V, Mariscotti C, Diamantini S.
    Minerva Dietol Gastroenterol; 1989 Jun 23; 35(1):1-6. PubMed ID: 2566959
    [Abstract] [Full Text] [Related]

  • 25. [Histamine H2-receptor antagonists as new anti-ulcer agents].
    Takemoto T.
    Nihon Rinsho; 1984 Jan 23; 42(1):103-13. PubMed ID: 6143835
    [No Abstract] [Full Text] [Related]

  • 26. The histological maturity of regenerating mucosa of healed duodenal ulcer and ulcer recurrence after treatment with H2-antagonist.
    Pan S, Liao CH.
    Am J Gastroenterol; 1990 Aug 23; 85(8):949-52. PubMed ID: 1973870
    [Abstract] [Full Text] [Related]

  • 27. Progress with proton pump inhibitors in acid peptic disease: treatment of duodenal and gastric ulcer.
    Florent C.
    Clin Ther; 1993 Aug 23; 15 Suppl B():14-21. PubMed ID: 7911399
    [Abstract] [Full Text] [Related]

  • 28. [The status of H2-blocker therapy today].
    Rameis H.
    Wien Med Wochenschr; 1992 Aug 23; 142(18):398-405. PubMed ID: 1362029
    [Abstract] [Full Text] [Related]

  • 29. Impact of ranitidine on prognosis after simple closure of perforated duodenal ulcer.
    Singh K, Chhina RS, Ghosh A, Kaura R.
    Trop Gastroenterol; 1999 Aug 23; 20(2):90-2. PubMed ID: 10484900
    [Abstract] [Full Text] [Related]

  • 30. Comparison of the efficacy and safety of ebrotidine in the treatment of duodenal ulcer. A multicentre, double-blind, placebo-controlled phase II study.
    Gabryelewicz A, Czajkowski A, Skrodzka D, Marlicz K, Luca de Tena F, Aldeguer M, Chantar C, Márquez M, Torres J, Ortiz JA.
    Arzneimittelforschung; 1997 Apr 23; 47(4A):545-50. PubMed ID: 9205762
    [Abstract] [Full Text] [Related]

  • 31. New H2-receptor antagonist--roxatidine acetate--in treatment of duodenal ulcer.
    Amarapurkar DN, Parikh SS, Desai HG.
    J Assoc Physicians India; 1993 Aug 23; 41(8):496-7. PubMed ID: 7904993
    [Abstract] [Full Text] [Related]

  • 32. Famotidine in the management of duodenal ulcer: an analysis of multicenter findings worldwide.
    Reynolds JC.
    Clin Ther; 1988 Aug 23; 10(4):436-49. PubMed ID: 3079011
    [Abstract] [Full Text] [Related]

  • 33. [A clinico-endoscopic study on cicatrization of lesions and prevention of recurrences in patients with liver cirrhosis and peptic ulcer].
    Di Mario F, Gottardello L, Burra P, Salvagnini M, Dalrì L, Leandro G, Contento F, Torri A, Naccarato R.
    G Clin Med; 1990 Apr 23; 71(4):259-62, 265-6. PubMed ID: 1973392
    [Abstract] [Full Text] [Related]

  • 34. [Effectiveness and tolerance of selected Polish antacids in the therapy of duodenal ulcer disease. A placebo- and ranitidine-controlled study].
    Mach T.
    Pol Tyg Lek; 1995 Apr 23; 50(1-35):797-800. PubMed ID: 11785199
    [Abstract] [Full Text] [Related]

  • 35. Effect of sucralfate on peptic ulcer recurrence: a controlled double-blind multicenter study.
    Classen M, Bethge H, Brunner G, Dirr B, Frotz H, Gabor M, Gail H, Grabner R, Hagenmüller F, Heinkel K.
    Scand J Gastroenterol Suppl; 1983 Apr 23; 83():61-8. PubMed ID: 6356323
    [Abstract] [Full Text] [Related]

  • 36. Peptic ulceration and its correlation with symptoms.
    Misiewicz JJ.
    Clin Gastroenterol; 1978 Sep 23; 7(3):571-82. PubMed ID: 361302
    [Abstract] [Full Text] [Related]

  • 37. Long-term treatment for gastric and duodenal ulcer.
    Di Mario F, Battaglia G, Pasqualetti P, Vio A, Gottardello L, Grassi SA.
    Ital J Gastroenterol; 1990 Sep 23; 22 Suppl 2():24-8. PubMed ID: 1983413
    [Abstract] [Full Text] [Related]

  • 38. Double blind controlled trial with oxmetidine and cimetidine in the short-term treatment of duodenal ulcer.
    Corinaldesi R, Galassi A, Borghi C, Pasquali R, Miglioli M, Sacco T, Barbara L.
    Hepatogastroenterology; 1981 Dec 23; 28(6):319-21. PubMed ID: 7047341
    [Abstract] [Full Text] [Related]

  • 39. [Ranitidine in the treatment of duodenal ulcer. Initial clinical experience with 33 patients].
    Noya G, Dettori G, Antona C, Niolu P, Muscas A, Marongiu G, Biglioli P.
    Minerva Med; 1983 Mar 31; 74(13):691-3. PubMed ID: 6132353
    [Abstract] [Full Text] [Related]

  • 40. Economic and health aspects of peptic ulcer disease and H2-receptor antagonists.
    Jensen DM.
    Am J Med; 1986 Oct 24; 81(4B):42-8. PubMed ID: 2877574
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.